Alnylam: Q1 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported a loss of $57.5 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of 44 cents per share. Losses, adjusted for one-time gains and costs, came to 1 cent per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.
The RNA interference drug developer posted revenue of $594.2 million in the period, which also beat Street forecasts. Eleven analysts surveyed by Zacks expected $588.2 million.
Alnylam shares have risen 12% since the beginning of the year. The stock has increased 83% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALNY at https://www.zacks.com/ap/ALNY
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Nvidia chief calls AI ‘the greatest equalizer' — but warns Europe risks falling behind
PARIS (AP) — Will artificial intelligence save humanity — or destroy it? Lift up the world's poorest — or tighten the grip of a tech elite? Jensen Huang, the global chip tycoon, offered his opinion on Wednesday: neither dystopia nor domination. AI, he said, is a tool for liberation. Wearing his signature biker jacket and mobbed by fans for selfies, the Nvidia CEO cut the figure of a tech rockstar as he took the stage at VivaTech in Paris. 'AI is the greatest equalizer of people the world has ever created,' Huang said, kicking off one of Europe's biggest technology industry fairs. But beyond the sheeny optics, Nvidia used the Paris summit to unveil a wave of infrastructure announcements across Europe, signaling a dramatic expansion of the AI chipmaker's physical and strategic footprint on the continent. In France, the company is deploying 18,000 of its new Blackwell chips with startup Mistral AI. In Germany, it's building an industrial AI cloud to support manufacturers. Similar rollouts are underway in Italy, Spain, Finland and the U.K., including a new AI lab in Britain. Other announcements include a partnership with AI startup Perplexity to bring sovereign AI models to European publishers and telecoms, a new cloud platform with Mistral AI, and work with BMW and Mercedes-Benz to train AI-powered robots for use in auto plants. The announcements reflect how central AI infrastructure has become to global strategy, and how Nvidia — the world's most valuable chipmaker — is positioning itself as the engine behind it. At the center of the debate is Huang's concept of the AI factory: not a plant that makes goods, but a vast data center that creates intelligence. These facilities train language models, simulate new drugs, detect cancer in scans, and more. Asked if such systems risk creating a 'technological priesthood' — hoarding computing power and stymying the bottom-up innovation that fueled the tech industry for the past 50 years — Huang pushed back. 'Through the velocity of our innovation, we democratize,' he told The Associated Press. 'We lower the cost of access to technology.' As Huang put it, these factories 'reason,' 'plan,' and 'spend a lot of time talking to' themselves, powering everything from ChatGPT to autonomous vehicles and diagnostics. But some critics warn that without guardrails, such all-seeing, self-reinforcing systems could go the way of Skynet in ' The Terminator ' movie — vast intelligence engines that outpace human control. 'Just as electricity powered the last industrial revolution, AI will power the next one,' he said. 'Every country now needs a national intelligence infrastructure.' He added: 'AI factories are now part of a country's infrastructure. That's why you see me running around the world talking to heads of state — they all want AI to be part of their infrastructure. They want AI to be a growth manufacturing industry for them.' Europe, long praised for its leadership on digital rights, now finds itself at a crossroads. As Brussels pushes forward with world-first AI regulations, some warn that over-caution could cost the bloc its place in the global race. With the U.S. and China surging ahead and most major AI firms based elsewhere, the risk isn't just falling behind — it's becoming irrelevant. Huang has a different vision: sovereign AI. Not isolation, but autonomy — building national AI systems aligned with local values, independent of foreign tech giants. 'The data belongs to you,' Huang said. 'It belongs to your people, your country... your culture, your history, your common sense.' But fears over AI misuse remain potent — from surveillance and deepfake propaganda to job losses and algorithmic discrimination. Huang doesn't deny the risks. But he insists the technology can be kept in check — by itself. 'In the future, the AI that is doing the task is going to be surrounded by 70 or 80 other AIs that are supervising it, observing it, guarding it, ensuring that it doesn't go off the rails.' The VivaTech event was part of Huang's broader European tour. He had already appeared at London Tech Week and is scheduled to visit Germany. In Paris, he joined French President Emmanuel Macron and Mistral AI CEO Arthur Mensch to reinforce his message that AI is now a national priority. — Chan reported from London.
San Francisco Chronicle
35 minutes ago
- San Francisco Chronicle
Missouri approves stadium aid for Kansas City Chiefs and Royals and disaster relief for St. Louis
JEFFERSON CITY, Mo. (AP) — Missouri lawmakers on Wednesday approved hundreds of millions of dollars of financial aid to try to persuade the Kansas City Chiefs and Royals to remain in the state and help the St. Louis area recover from a devastating tornado. House passage sends the legislative package to Republican Gov. Mike Kehoe, who called lawmakers into special session with a plea for urgent action. Kehoe is expected to sign the measures into law. Missouri's session paired two otherwise unrelated national trends — a movement for new taxpayer-funded sports stadiums and a reevaluation of states' roles in natural disasters as President Donald Trump's administration reassess federal aid programs. The stadium subsidies already were a top concern in Missouri when a deadly tornado struck St. Louis on May 16, causing an estimated $1.6 billion of damage a day after lawmakers had wrapped up work in their annual regular session. The disaster relief had widespread support. Lawmakers listened attentively on Wednesday as Democratic state Rep. Kimberly-Ann Collins described with a cracking voice how she witnessed the tornado rip the roof off her house and damage her St. Louis neighborhood. Collins said she has no home insurance, slept in her car for days and has accepted food from others. 'Homes are crumbled and leveled,' said Collins, adding: 'It hurts me to my core to see the families that have worked so hard, the businesses that have worked so hard, to see them ripped apart.' Lawmakers approved $100 million of open-ended aid for St. Louis and $25 million for emergency housing assistance in any areas covered under requests for presidential disaster declarations. They also authorized a $5,000 income tax credit to offset insurance policy deductibles for homeowners and renters hit by this year's storms — a provision that state budget director Dan Haug said could eventually cost up to $600 million. The Chiefs and Royals currently play football and baseball in side-by-side stadiums in Jackson County, Missouri, under leases that expire in January 2031. Jackson County voters last year defeated a sales tax extension that would have helped finance an $800 million renovation of the Chiefs' Arrowhead Stadium and a $2 billion ballpark district for the Royals in downtown Kansas City. That prompted lawmakers in neighboring Kansas last year to authorize bonds for up to 70% of the cost of new stadiums in Kansas to lure the teams to their state. The Royals have bought a mortgage for property in Kansas, though the team also has continued to pursue other possible sites in Missouri. The Kansas offer is scheduled to expire June 30, creating urgency for Missouri to approve a counter-offer. Missouri's legislation authorizes bonds covering up to 50% of the cost of new or renovated stadiums, plus up to $50 million of tax credits for each stadium and unspecified aid from local governments. If they choose to stay in Missouri, the Chiefs plan a $1.15 billion renovation of Arrowhead Stadium. Though they have no specific plans in the works, the St. Louis Cardinals also would be eligible for stadium aid if they undertake a project of at least $500 million. Many economists contend public funding for stadiums isn't worth it, because sports tend to divert discretionary spending away from other forms of entertainment rather than generate new income. But supporters said Missouri stands to lose millions of dollars of tax revenue if Kansas City's most prominent professional sports teams move to Kansas. They said Missouri's reputation also would take a hit, particularly if it loses the Chiefs, which have won three of the past six Super Bowls. 'We have the chance to maybe save what is the symbol of this state,' Rep. Jim Murphy, a Republican from St. Louis County, said while illustrating cross-state support for the measure. The legislation faced some bipartisan pushback from those who described it as a subsidy for wealthy sports team owners. Others raised concerns that a property tax break for homeowners, which was added in the Senate to gain votes, violates the state constitution by providing different levels of tax relief in various counties while excluding others entirely.
Los Angeles Times
39 minutes ago
- Los Angeles Times
States sue to block the sale of genetic data collected by DNA testing company 23andMe
Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company's sale of its customers' genetic data without explicit consent. The suit, filed this week in U.S. Bankruptcy Court in the Eastern District of Missouri, comes months after 23andMe began a court-supervised sale process of its assets. The South San Francisco-based venture was once valued at $6 billion and has collected DNA samples from more than 15 million customers. The company's bankruptcy has raised questions over privacy standards for genetic data, which experts say is uniquely sensitive, immutable and irreplaceable if stolen. Twenty-seven states and the District of Columbia filed the lawsuit, arguing that 23andMe customers have an inherent right to their own genetic information. 'This isn't just data — it's your DNA,' said Oregon Atty. Gen. Dan Rayfield in a statement. 'It's personal, permanent, and deeply private. People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest bidder.' 23andMe announced in May that it would be sold to New York-based drug maker Regeneron Pharmaceuticals, which had agreed to comply with 23andMe's existing privacy policy. However, a competing offer from nonprofit TTAM Research Institute led the bankruptcy judge to reopen the auction last week. TTAM is run by 23andMe co-founder Anne Wojcicki, who has made several failed attempts to take the company private. In a statement, a 23andMe spokesperson said the lawsuit's claims 'are without merit' and that the sale of genetic data does not violate privacy regulations. 'Customers will continue to have the same rights and protections in the hands of the winning bidder,' the spokesperson said. 23andMe customers have the right to delete their genetic information from the company's database at any time, as outlined in the Genetic Information Privacy Act and the California Consumer Privacy Act. During a testimony in Washington earlier this week, 23andMe interim Chief Executive Joseph Selsavage said that 1.9 million customers have requested their data be deleted since the company's bankruptcy filing in March. Sara Geoghegan, senior counsel at the Electronic Privacy Information Center, said that 23andMe's privacy policy was subject to change and not adequate to protect customers' data. In an interview in March, she stressed the sensitivity of genetic data. 'I would be very concerned if I had given a swab to 23andMe,' she said. 'There is little we can do to control what happens to it.'
